Joël Mossong

Directorate of Health — IS

Agricultural and Biological Sciences · Life Sciences

47h-index12.8kcitations176works15.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Salmonella and Campylobacter epidemiology(23), COVID-19 epidemiological studies(22), Vaccine Coverage and Hesitancy(22), Viral gastroenteritis research and epidemiology(22), SARS-CoV-2 and COVID-19 Research(21)

Publications176 total

Protection from second booster vaccines and natural immunity against SARS-CoV-2 infections, 2022–2023
Epidemiology and Infection·2025Open Access
Insights into recurring multi-country outbreaks of $Salmonella$ Strathcona associated with tomatoes, Europe, 2011 to 2024
Universität Zürich, ZORA·2025Open Access
Insights into recurring multi-country outbreaks of Salmonella Strathcona associated with tomatoes, Europe, 2011 to 2024
Eurosurveillance·2025· 2 citedOpen Access
Shiga toxin-producing Escherichia coli O26:H11 associated with a cluster of haemolytic uraemic syndrome cases following the mid-July 2021 floods in Belgium
Journal of Infection and Public Health·2025Open Access
Influenza RNA fluxes monitoring in wastewater as a complementary epidemiological surveillance indicator: A four-year nationwide study in Luxembourg
The Science of The Total Environment·2025· 1 citedOpen Access
Nightlife and low immunity drove transmission of SARS-CoV-2 gamma in Luxembourg, 2021
Scientific Reports·2025Open Access
Key role of whole genome sequencing in resolving an international outbreak of monophasic Salmonella Typhimurium linked to chocolate products
BMC Infectious Diseases·2025· 4 citedOpen Access
Case-only analysis of routine surveillance data: detection of increased vaccine breakthrough infections with SARS-CoV-2 variants in Europe
Epidemiology and Infection·2025· 2 citedOpen Access
Trends in new HIV diagnoses and factors contributing to late diagnosis among migrant populations in EU/EEA countries, 2014 to 2023
Eurosurveillance·2024· 3 citedOpen Access
Diverse roles of Primary Health Care in COVID-19 vaccination across 28 European countries – Insights from the Eurodata study
European Journal of General Practice·2024· 2 citedOpen Access
Estimated number of lives directly saved by COVID-19 vaccination programmes in the WHO European Region from December, 2020, to March, 2023: a retrospective surveillance study
The Lancet Respiratory Medicine·2024· 80 citedOpen Access
High vaccine effectiveness against severe COVID-19 outcomes and population preventable fraction during the Omicron era in Luxembourg: A nationwide retrospective risk factor analysis
Vaccine·2024· 3 citedOpen Access
Impact of nirsevimab prophylaxis on paediatric respiratory syncytial virus (RSV)-related hospitalisations during the initial 2023/24 season in Luxembourg
Eurosurveillance·2024· 122 citedOpen Access
High Vaccine Effectiveness Against Severe Covid-19 Outcomes During the Omicron Era in Luxembourg: A Nationwide Retrospective Cohort Study (December 2021-March 2023)
SSRN Electronic Journal·2024Open Access
A standardised protocol for relative SARS-CoV-2 variant severity assessment, applied to Omicron BA.1 and Delta in six European countries, October 2021 to February 2022
Eurosurveillance·2023· 7 citedOpen Access
Effects of bivalent Omicron-containing vaccine boosters and prior infection against SARS-CoV-2 Omicron infections in Luxembourg, September-December 2022
Population Medicine·2023Open Access
Multisystem inflammatory syndrome in children during the first two years of the COVID-19 pandemic in Luxembourg
Frontiers in Pediatrics·2023· 7 citedOpen Access
A standardised protocol for assessment of relative SARS-CoV-2 variant severity, with application to severity risk for COVID-19 cases infected with Omicron BA.1 compared to Delta variants in six European countries
arXiv (Cornell University)·2023Open Access
A Molecular and Epidemiological Investigation of a Large SARS-CoV-2 Outbreak in a Long-Term Care Facility in Luxembourg, 2021
Geriatrics·2023· 2 citedOpen Access
A Standardised Protocol for Assessment of Relative SARS-CoV-2 Variant Severity, with Application to Severity Risk for COVID-19 Cases Infected with Omicron BA.1 Compared to Delta Variants in six European Countries
SSRN Electronic Journal·2023· 1 citedOpen Access
page 1 of 9Next →

Frequent Co-authors

Richard Pebody(8), Catherine Ragimbeau(7), Nick Andrews(6), F Schneider(6), Anne Vergison(5), Irja Davidkin(5), George Kafatos(5), Flavia Riccardo(4), Dani Cohen(4), M Sláčiková(4), Angelos Hatzakis(4), Anthony Nardone(4), Niel Hens(3), Philippe Beutels(3), Małgorzata Sadkowska-Todys(3), W. John Edmunds(3), Serge Losch(3), Piers Mook(3), Clara Mazagatos(3), Jan Kynčl(3)